Hans‐Jürgen Stellbrink

机构：Infektionsmedizinisches Centrum Hamburg

发表论文 137 篇 · 总被引 8859 次 · h-index 42

代表论文

• Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (2022 · New England Journal of Medicine · 被引 312)
• Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study (2021 · The Lancet HIV · 被引 143)
• Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials (2021 · Clinical Infectious Diseases · 被引 119)
• Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials (2023 · EClinicalMedicine · 被引 90)
• A highly virulent variant of HIV-1 circulating in the Netherlands (2022 · Science · 被引 76)
• Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial (2023 · The Lancet HIV · 被引 71)